// App-Quantinova.ai

: Evaluation of the Predictive Value of the Bleeding Prediction Score “VTE‐BLEED” for Recurrent Venous Thromboembolism

Researchers

Presenter

  • F. Klok

Principal Investigators

  • C. Tromeur

  • S. Barco

  • S. Konstantinides

  • O. Sanchez

  • G. Pernod

  • L. Raj

  • P. Robin

  • P.-Y. Le Roux

  • C. Hoffman

  • S. Mlac

  • L. Bertoletti

  • P. Girard

  • S. Laporte

  • P. Mismetti

  • G. Meyer

  • C. Leroyer

  • F. Couturaud

Medical Centers

  • LUMC, Leiden, Netherlands

  • Centre Hospitalo-Universitaire, Brest, France

  • Centre Hospitalo‐Universitaire de Brest, Saint‐Etienne, France

  • CTH Mainz, Mainz, Germany

  • Université Paris Descartes, Université Sorbonne Paris Cité, INSERM, UMR_S1140, Paris, France

  • Centre Hospitalier Universitaire de Grenoble, Grenoble, France

  • Innovation et Pharmacologie, Centre Hospitalo‐Universitaire de Saint‐Etienne, Saint‐Etienne, France

  • Centre Hospitalo‐Universitaire de Brest, Saint‐Etienne, France

  • CHU Saint-Etienne, Saint Etienne, France

  • Institut Mutualiste Montsouris, Paris, France

  • Universite Paris Sorbonne Paris Cite, Paris, France

Locations

  • Netherlands

  • France

  • Germany

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

  • Blood/haematological Diseases

  • Cardiovascular (CVS)

Disease

  • Venous thrombosis

  • Pulmonary embolism

Biomarkers

  • N/A

Drug/Treatment

  • Warfarin

Outcome

  • N/A

Study Design

  • Randomized

  • Placebo Control

  • Double Blind/Blinded

  • Controlled

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved